Loading
Latest filing published 25 Sept 2026 for Telix Pharmaceuticals Limited, €82k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of David Gill in Telix Pharmaceuticals Limited. Between 13 May 2026 and 24 September 2026, the trades on record add up to 4 filings.
Both buying and selling appear: 2 purchases worth €141k, against 1 sale worth €6. On balance, insiders were net buyers of €141k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 25 September 2026 came the latest disclosure, an open-market purchase for €82k in Telix Pharmaceuticals Limited. Between a trade and the moment it shows up on ASX, the median delay is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations